Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial

This study has been completed.
Information provided by:
Hospital de Clinicas de Porto Alegre Identifier:
First received: January 30, 2007
Last updated: January 31, 2007
Last verified: January 2007
Highly active antiretroviral therapy (HAART) in HIV-positive patients is associated with the development of dyslipidemia, a risk factor for cardiovascular events. The objective of this study was to evaluate the effect of dietary intervention in individuals who start HAART.

Condition Intervention
HIV Infections
Behavioral: Nutritional

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start on Highly Active Antiretroviral Therapy: a Randomized Trial

Resource links provided by NLM:

Further study details as provided by Hospital de Clinicas de Porto Alegre:

Primary Outcome Measures:
  • Total cholesterol and of triglycerides levels

Secondary Outcome Measures:
  • HDL-cholesterol, LDL-cholesterol, weight, waist to hip ratio

Estimated Enrollment: 80
Study Start Date: March 2004
Estimated Study Completion Date: February 2007
Detailed Description:

Adult patients prescribed to HAART that met the exclusion criteria were consecutively enrolled in a randomized trial:

  • control (receiving general guidelines on dietary education)
  • intervention (receiving general guidelines on dietary education and nutritional follow-up every 3 months)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • HIV-positive individuals naive to HAART, with clinical indication to start therapy

Exclusion Criteria:

  • Diabetes Mellitus
  • Pregnancy
  • Active opportunistic disease
  • Any mental deficiency
  • Use of lipid profile influencing drugs
  • Use of illicit drugs
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00429845

Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-003
Sponsors and Collaborators
Hospital de Clinicas de Porto Alegre
Principal Investigator: Jorge P Ribeiro, MD, ScD Associate Professor and Chief of Non-invasive Cardiology
  More Information

Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00429845     History of Changes
Other Study ID Numbers: HCPA2004-012
Study First Received: January 30, 2007
Last Updated: January 31, 2007

Keywords provided by Hospital de Clinicas de Porto Alegre:

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases processed this record on May 25, 2017